Károly Szepesházi

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

Attila Nagy, Andrew V. Schally, Patricia Armatis et al. · Proceedings of the National Academy of Sciences · 1996 · 203 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin

Attila Nagy, Andrew V. Schally, Gábor Halmos et al. · Proceedings of the National Academy of Sciences · 1998 · 144 citations

Medicine, Medicinal Chemistry, Pharmacology +11

The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues

Alexandre Havt, Andrew V. Schally, Gábor Halmos et al. · Proceedings of the National Academy of Sciences · 2005 · 118 citations · Full text

Medicine, Molecular Biology, Oncology +17

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II

A. Jungwirth, J. Pinski, Georg Galvan et al. · European Journal of Cancer · 1997 · 96 citations · Full text

Medicine, Oncology, Pharmacology +12

Inhibition of Growth of Human Osteosarcomas by Antagonists of Growth Hormone-Releasing Hormone

J. Pinski, Andrew V. Schally, Kate Groot et al. · JNCI Journal of the National Cancer Institute · 1995 · 91 citations

Medicine, Endocrinology, Oncology +8